InsiderTrades

Form 4 for UTHR UNITED THERAPEUTICS Corp

Accepted 2024-09-10 00:00:00 ET · period of report 2024-09-09 · accession 0001415889-24-023132 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-09-10 2024-09-09 UTHR EDGEMOND JAMES CFO AND Treas S - Sale+OE $345.41 -7,802 3,210 -71% -$2.69M
DM 2024-09-10 2024-09-09 UTHR EDGEMOND JAMES CFO AND Treas M - OptEx $118.98 +8,332 4,318 New +$991.4K
DM 2024-09-10 2024-09-09 UTHR EDGEMOND JAMES CFO AND Treas M - OptEx $0.00 -8,332 145.5K -5% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-09-09 S D 3,400 $345.41 3,210 D — —
2 Common Common Stock 2024-09-09 M A 3,400 $117.76 6,610 D — —
3 Common Common Stock 2024-09-09 M A 3,266 $120.26 6,476 D — — (F2) Includes 48 shares of common stock acquired on September 4, 2024 under the United Therapeutics Corporation Employee Stock Purchase Plan.
4 Common Common Stock 2024-09-09 M A 816 $120.26 4,026 D — —
5 Common Common Stock 2024-09-09 S D 558 $345.41 3,468 D — —
6 Common Common Stock 2024-09-09 M A 850 $117.76 4,318 D — —
7 Common Common Stock 2024-09-09 S D 578 $345.41 3,740 D — —
8 Common Common Stock 2024-09-09 S D 3,266 $345.41 3,210 D — —
9 Derivative Stock Options 2024-09-09 M D 816 $0.00 32,672 D $120.26 · 2017-03-15 to 2026-03-15 816 Common Stock
10 Derivative Stock Options 2024-09-09 M D 3,400 $0.00 146,350 D $117.76 · 2021-03-15 to 2027-03-15 3,400 Common Stock
11 Derivative Stock Options 2024-09-09 M D 3,266 $0.00 33,488 D $120.26 · 2017-03-15 to 2026-03-15 3,266 Common Stock
12 Derivative Stock Options 2024-09-09 M D 850 $0.00 145,500 D $117.76 · 2021-03-15 to 2027-03-15 850 Common Stock